Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Goodbody Health's share price for the quarter that ended in Sep. 2022 was £0.13. Goodbody Health's Shares Outstanding (EOP) for the quarter that ended in Sep. 2022 was 36.50 Mil. Therefore, Goodbody Health's market cap for the quarter that ended in Sep. 2022 was £4.74 Mil.
Goodbody Health's quarterly market cap
declined
from Mar. 2022 (£11.31 Mil) to Jun. 2022 (£4.93 Mil) and
declined
from Jun. 2022 (£4.93 Mil) to Sep. 2022 (£4.74 Mil).
Goodbody Health's annual market cap
stayed the same
from Jul. 2019 (£0.00 Mil) to Jul. 2020 (£0.00 Mil) but then
increased
from Jul. 2020 (£0.00 Mil) to Dec. 2021 (£13.32 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Goodbody Health's Enterprise Value for Today is £-2.82 Mil.
Goodbody Health Market Cap Historical Data
The historical data trend for Goodbody Health's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Goodbody Health's Market Cap
For the Drug Manufacturers - Specialty & Generic subindustry, Goodbody Health's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Goodbody Health's Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Goodbody Health's Market Cap distribution charts can be found below:
* The bar in red indicates where Goodbody Health's Market Cap falls into.
Goodbody Health Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Goodbody Health's Market Cap for the fiscal year that ended in Dec. 2021 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Goodbody Health (AQSE:GDBY) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Goodbody Health Market Cap Related Terms
Thank you for viewing the detailed overview of Goodbody Health's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Goodbody Health Ltd is a wellness company operating in both COVID testing in the United Kingdom and as a vertically integrated cannabinoid CBD company that operates in the United Kingdom and the European Union. It has interests in COVID testing clinics, CBD extraction, wholesale bulk isolate, and distillate sales, retail CBD and white label sales, cannabinoid laboratory testing, and medicinal cannabis research programs.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AQSE:GDBY has been successfully added to your 